Fuse Oncology has filed a notice of an exempt offering of securities to raise $8,860,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Fuse Oncology is raising $8,860,000.00 in new funding. Sources indicate that as part of senior management Chief Financial Officer, James Bauler played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Fuse Oncology
Fuse Oncology delivers SaaS solutions that break down healthcare workflow and data silos to create a seamless experience for clinicians in radiation oncology. By placing the broader electronic medical record system at the center of the architecture, Fuse eliminates duplicative and inefficient efforts to enable a future where oncology care moves at the speed of patients. Initiate treatment within 24 hours and reduce clinician workload. With a team centric user experience were re-envisioning practice management. We focus on the essentials first, ensuring the best possible outcomes.
To learn more about Fuse Oncology, visit http://fuseonc.com/
Contact:
James Bauler, Chief Financial Officer
828-719-8279
https://www.linkedin.com/in/james-bauler-ma-8024365/
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.